drugset / Trial / NCT05458375

Vaginal Estradiol Use in Pessary Care

NCT05458375

Phase 0 Terminated 11 enrolled University of South Florida
RandomizedSingle-groupOpen-labelSupportive care

Summary

The primary outcome of this study compare the rate of pessary discontinuation at 6 months post-pessary fitting in women using vaginal estradiol versus those not using vaginal estradiol.

Timeline

Start
2022-12-29
Primary completion
2023-04-26
Completion
2023-04-26

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Estradiol Other / unclassified Other

Indications